tiprankstipranks
Advertisement
Advertisement

IMRX Stock Latest News

Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
The FlyZillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
14d ago
Z
ZG
Immuneering initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Immuneering initiated with a Buy at H.C. Wainwright
14d ago
IMRX
Ami Fadia Raises IMRX Price Target to $18 on Strong Phase 3 Progress and Favorable PDAC Treatment Positioning
PremiumRatings
Ami Fadia Raises IMRX Price Target to $18 on Strong Phase 3 Progress and Favorable PDAC Treatment Positioning
15d ago
IMRX
Immuneering reports Q2 EPS 927c), consensus (27c)
PremiumThe Fly
Immuneering reports Q2 EPS 927c), consensus (27c)
15d ago
IMRX
Immuneering publishes preclinical data on atebimetinib in Cancer Research
PremiumThe Fly
Immuneering publishes preclinical data on atebimetinib in Cancer Research
30d ago
IMRX
Immuneering initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyImmuneering initiated with an Overweight at Cantor Fitzgerald
1M ago
IMRX
Immuneering Appoints Veteran Biotech Leader as New CFO
Premium
Company Announcements
Immuneering Appoints Veteran Biotech Leader as New CFO
2M ago
8K
IMRX
Immuneering appoints Andrew Gengos as CFO
Premium
The Fly
Immuneering appoints Andrew Gengos as CFO
2M ago
IMRX
Immuneering Shareholders Approve Directors and Auditor at Meeting
PremiumCompany Announcements
Immuneering Shareholders Approve Directors and Auditor at Meeting
2M ago
8K
IMRX
Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained
PremiumRatings
Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained
3M ago
IMRX
Immuneering Advances Atebimetinib With Positive Phase 2a Results
PremiumCompany Announcements
Immuneering Advances Atebimetinib With Positive Phase 2a Results
3M ago
8K
IMRX
Midday Fly By: Nvidia unveils new PC chip, Berkshire to buy Taylor Morrison
PremiumThe Fly
Midday Fly By: Nvidia unveils new PC chip, Berkshire to buy Taylor Morrison
3M ago
GM
AMC
Immuneering announces updated clinical data from atebimetinib combination trial
PremiumThe FlyImmuneering announces updated clinical data from atebimetinib combination trial
3M ago
IMRX
Immuneering reports Q1 EPS (21c), consensus (25c)
Premium
The Fly
Immuneering reports Q1 EPS (21c), consensus (25c)
3M ago
IMRX
Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
Premium
Company Announcements
Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
4M ago
IMRX
Immuneering announces updated data from Phase 2a trial for atebimetinib
PremiumThe Fly
Immuneering announces updated data from Phase 2a trial for atebimetinib
4M ago
IMRX
Immuneering announces presentation of new genetic data at 2026 AACR
PremiumThe Fly
Immuneering announces presentation of new genetic data at 2026 AACR
4M ago
IMRX
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
4M ago
ANGX
IMRX
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
5M ago
EVAX
IMRX
3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
5M ago
MWH
AKTS
Immuneering price target lowered to $12 from $13 at Piper Sandler
Premium
The Fly
Immuneering price target lowered to $12 from $13 at Piper Sandler
5M ago
IMRX
Advancing Atebimetinib Pipeline and Strong Cash Runway Underpin Buy Rating on Immuneering
Premium
Ratings
Advancing Atebimetinib Pipeline and Strong Cash Runway Underpin Buy Rating on Immuneering
5M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >